Carolinas HealthCare System

Research and Clinical Trials

Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV: The REALM Study
Brief Description  
Observational study of patients who are initiating or modifying their therapy for chronic hepatitis B. They will receive either entecavir or another standard of care HBV nucleoside/tide analogue.
Who may be Eligible  
Patients with chronic HBV infection, and are appropriate for a study regimen of nucleoside/tide monotherapy
Hepatitis B
IRB Number  
Principal Investigator  
Russo, Mark

For More Information, Contact   Gale  W.  Groseclose , RN
Phone:  (704) 355-4875  Fax:  (704) 355-8147 
Address:  Carolinas Medical Center 1000 Blythe Boulevard Medical Education Building, Ste. 103 Charlotte, NC 28203